This protocol is judged by an institutional evaluation board, an unbiased team that opinions any clinical trials involving human beings. If a research will involve a Timetable I drug, when the board approves the protocol as ethical, the researchers need to make an application for an investigational new drug (IND) variety with the FDA.Consumers note